查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球眼科黏彈性器材市場評估：依產品類型、成分、應用、最終用戶、地區、機會、預測（2017-2031）
市場調查報告書
商品編碼
1417592

全球眼科黏彈性器材市場評估：依產品類型、成分、應用、最終用戶、地區、機會、預測（2017-2031）

Ophthalmic Viscoelastic Devices Market Assessment, By Product Type, By Composition, By Application, By End-user, By Region, Opportunities and Forecast, 2017-2031F
出版日期: | 出版商: Market Xcel - Markets and Data | 英文 242 Pages | 商品交期: 3-5個工作天內

價格

全球眼科黏彈性器材市場規模預計到2023年將達到30.1億美元，到2031年將達到44.8億美元，2023-2031年預測期間複合年增長率為5.1%。由於眼科疾病盛行率的增加、老年人口的增加以及眼科設備的進步等主要因素，全球眼科黏彈性設備市場正在呈現顯著成長。此外，生活方式的改變、螢幕時間的增加以及慢性病盛行率的上升導致眼部疾病患者數量的增加，從而推動了對眼科黏彈性裝置的需求。

由於白內障、青光眼、角膜移植和玻璃體視網膜手術等各種手術的需求不斷增加，預計眼科黏彈性裝置市場將顯著成長。老年人群特別容易出現視力障礙，進一步增加了對眼科黏彈性裝置的需求。此外，糖尿病、高血壓等慢性病的流行也對市場產生影響，而這些疾病往往伴隨眼部疾病。技術進步、支持醫療基礎設施的政府政策以及醫療設備的可用性正在推動市場成長。然而，手術後眼壓升高的風險以及替代療法的存在等問題可能會阻礙市場擴張。

2023年4月，Bausch + Lomb Corporation宣佈在美國市場推出兩款黏彈性裝置：StableVisc cohesive OVD和TotalVisc Viscoelastic System。這兩種裝置均含有透明質酸鈉和山梨醇的混合物，與其他可用的眼科黏彈性裝置相比，可提供強大的物理屏障並增強自由基清除能力。

眼科疾病盛行率上升

屈光不正、白內障、糖尿病性視網膜病變、青光眼和老年黃斑部病變（AMD）等眼科疾病的盛行率日益增加，對全球眼科黏彈性裝置（OVD）市場產生了重大影響。由於不健康的生活方式、營養不良和螢幕時間過長等因素，這些疾病呈現上升趨勢。這些疾病的日益普及預計將推動對廣泛用於眼科手術的眼科黏彈性裝置的需求。根據世界衛生組織 2023 年 8 月的情況說明書，全球有 22 億人患有近視或遠視。其中，10億人因遠視力障礙而失明，其中9,400萬人因白內障、8,840萬人因屈光不正、800萬人因老年黃斑部病變、770萬人因青光眼和390萬人因糖尿病視網膜病變而失明。老花眼影響 8.26 億人，是損害近距離視力的主要疾病。

老年人口增加

人口老化是導致眼科黏彈性裝置需求不斷增長的另一個重要面向。老年人更有可能患有影響眼睛的慢性疾病和眼科疾病。據世界衛生組織稱，到2030年，世界上六分之一的人將超過60歲。60歲以上人口將從2020年的10億增加到2030年的14億。到2050年，地球上60歲以上的人口數量將翻倍，達到21億人。預計到 2050 年，80 歲及以上的人口數量將翻兩番，達到 4.26 億。

黏性眼科黏彈性裝置占主導地位

預計在預測期內，黏性眼科黏彈性裝置領域將在全球眼科黏彈性裝置中佔據主導地位。黏性眼科黏彈性裝置被廣泛使用，因為它們具有高黏度（增加手術環境穩定性）和高黏性（有利於手術切除）等優點。這可以穩定結構並允許對其佔據的空間加壓。白內障盛行率的增加和眼科黏彈性裝置的技術進步是黏性眼科黏彈性裝置領域佔據主導地位的原因。市場公司正在擴大其產品組合，以獲得該產品類別的競爭優勢。

本報告研究分析了全球眼科黏彈性器材市場，提供市場規模和預測、市場動態、主要參與者現狀和前景等。

目錄

第一章研究方法論

第二章 專案範圍與定義

第三章執行摘要

第四章全球眼科黏彈器材市場展望（2017-2031）

  • 市場規模及預測
    • 金錢數額
    • 數量
  • 按產品類型
    • 黏性眼科黏彈性裝置
    • 分散型眼科黏彈裝置
    • 黏性適應性眼科黏彈性裝置
    • 高黏度分散眼科黏彈裝置
  • 按成分分類
    • 透明質酸鈉
    • 硫酸軟骨素
    • 羥丙基甲基纖維素
  • 按用途
    • 白內障手術
    • 青光眼手術
    • 玻璃體視網膜手術
    • 角膜移植手術
    • 其他用途
  • 按最終用戶
    • 醫院
    • 眼科診所
    • 門診手術中心
    • 學術、研究機構
    • 其他
  • 按地區
    • 北美
    • 歐洲
    • 亞太地區
    • 南美洲
    • 中東/非洲
  • 市場佔有率：依公司劃分（2023 年）

第五章全球眼科黏彈性裝置市場：按地區（2017-2031）

  • 北美
    • 市場規模及預測
    • 按產品類型
    • 按成分分類
    • 按用途
    • 按最終用戶
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 法國
    • 義大利
    • 英國
    • 俄羅斯
    • 荷蘭
    • 西班牙
    • 土耳其
    • 波蘭
  • 南美洲
    • 巴西
    • 阿根廷
  • 亞太地區
    • 印度
    • 中國
    • 日本
    • 澳大利亞
    • 越南
    • 韓國
    • 印度尼西亞
    • 菲律賓
  • 中東/非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合酋長國
    • 以色列
    • 南非

第六章 市場測繪（2023）

  • 按產品類型
  • 按成分分類
  • 按用途
  • 按最終用戶
  • 按地區

第七章 宏觀環境與產業結構

  • 供需分析
  • 進出口分析 - 數量和價值
  • 供應/價值鏈分析
  • PESTEL 分析
  • 波特五力分析

第八章市場動態

  • 增長動力
  • 成長限制因素（問題、限制因素）

第九章 監理架構與創新

  • 臨床試驗
  • 專利情況
  • 監管審批
  • 創新/新技術

第十章 主要公司情況

  • 前 5 名市場領導者的競爭矩陣
  • 前 5 名市場領導者的市場收入分析（2023 年）
  • 併購/合資（如適用）
  • SWOT分析（5家進入市場的公司）
  • 專利分析（如果適用）

第11章價格分析

第十二章案例研究

第十三章 主要公司展望

  • Johnson & Johnson Surgical Vision Inc.
  • Alcon Laboratories, Inc.
  • Carl Zeiss Meditec AG
  • Rumex International Corporation
  • Altacor Limited
  • Bausch & Lomb Incorporated
  • Novartis International AG
  • CVC Capital Partners SICAV- FIS SA
  • Eyekon Medical Inc.
  • Bohus BioTech AB
  • Beaver Visitec Limited
  • Neu Micromed International Pvt. Ltd.
  • Rayner Intraocular Lenses Limited

第十四章 戰略建議

第十五章 關於我們公司、免責聲明

Product Code: MX10886

Global ophthalmic viscoelastic devices market size was valued at USD 3.01 billion in 2023 and is expected to reach USD 4.48 billion in 2031, with a CAGR of 5.1% for the forecast period between 2023 and 2031F. The global market for ophthalmic viscoelastic devices is experiencing significant growth due to several key factors, such as the increasing prevalence of eye-related disorders, the growing elderly population, and advancements in ophthalmic devices. Additionally, lifestyle changes, prolonged screen time, and the rising incidence of chronic diseases contribute to more patients with eye disorders, driving the demand for ophthalmic viscoelastic devices.

The ophthalmic viscoelastic devices market is projected to grow substantially, driven by the increasing demand for various surgical procedures, including those related to cataracts, glaucoma, corneal transplantation, and vitreoretinal surgery. The geriatric population is particularly susceptible to vision impairment, further boosting the need for ophthalmic viscoelastic devices. Furthermore, the market is influenced by the prevalence of chronic conditions such as diabetes and hypertension, which are often associated with eye disorders. Technological advancements, government policies supporting healthcare infrastructure, and enhanced availability of medical devices are fueling the market growth. However, challenges such as the risk of a rise in ocular pressure after surgery and the presence of alternative therapies may impede market expansion.

In April 2023, Bausch + Lomb Corporation announced the launch of two viscoelastic devices, StableVisc cohesive ophthalmic viscosurgical device (OVD) and TotalVisc Viscoelastic System, in the United States market. Both the devices contain a mix of sodium hyaluronate and sorbitol, providing a strong physical barrier and delivering increased free radical scavenging capabilities compared to other available ophthalmic viscoelastic devices.

Rising Prevalence of Ophthalmic Disorders

The increasing prevalence of ophthalmic disorders, such as refractive errors, cataracts, diabetic retinopathy, glaucoma, and age-related macular degeneration (AMD), significantly impacts the global ophthalmic viscoelastic devices (OVDs) market. These disorders are on the rise due to factors like unhealthy lifestyles, nutritional deficiency, and longer screen time. The increasing prevalence of these diseases is expected to drive the demand for ophthalmic viscoelastic devices, as these devices are extensively used in ophthalmic surgeries. A WHO factsheet from August 2023 states that 2.2 billion people worldwide suffer from near or far-sightedness. Out of which, 1 billion are affected by blindness from distance vision impairment, including 94 million people with cataracts, 88.4 million with refractive error, 8 million with age-related macular degeneration, 7.7 million with glaucoma, and 3.9 million with diabetic retinopathy. Presbyopia, which affects 826 million people, is the main condition that impairs close vision.

Growing Geriatric Population

Another important aspect that has contributed significantly to the increased need for ophthalmic viscoelastic devices is the aging population. People who are older tend to have comorbid ailments such as chronic illnesses and ophthalmic disorders that affect their eyes. As per WHO, by 2030, one in six people in the world will be 60 years of age or older. By 2030, there will be 1.4 billion over-60s, compared to 1 billion in 2020. By 2050, there will be twice as many people 60 years or older on the planet, i.e., 2.1 billion people. It is projected that the population of 80 years of age or older will quadruple to 426 million by 2050.

Cohesive Ophthalmic Viscoelastic Devices to Dominate

The cohesive ophthalmic viscoelastic devices segment in global ophthalmic viscoelastic devices is expected to dominate during the forecast period. Cohesive ophthalmic viscoelastic devices are being used extensively as they offer advantages such as high viscosity, which increases the stability of the surgical environment, and high cohesion, which eases surgical removal. It stabilizes structures and enables pressurization of the space they occupy. The growing prevalence of cataracts and technological advancements in ophthalmic viscoelastic devices are reasons for the dominance of the cohesive ophthalmic viscoelastic devices segment. Market players are expanding their product portfolio to gain a competitive edge in this product category.

North America is Expected to Dominate

With high investment in research and development activities, technological advancements by key players, and advanced healthcare infrastructure in countries, like the United States and Canada, the region is expected to dominate the market with the highest value share. Supportive government initiatives for managing the growing number of ophthalmic surgeries are embracing the growth of the market in the region. High disposable income and preference for ophthalmic treatments of eye problems, along with the presence of key players, are contributing to the dominance of North America in the ophthalmic viscoelastic devices market.

Future Market Scenario

Growth in healthcare infrastructure in developing countries and efforts to reduce the burden of ophthalmic disorders like integrated people-centered eye care (IPEC) by WHO is expected to set a positive trend for the market. Key market players focus on developing innovative products and expanding their market presence. In terms of regional growth, Asia-Pacific market is expected to experience a robust CAGR, driven by its sizable population, rising disposable income, and growing patient awareness of the need for eye care. In the future, surgeons might be able to carry out more intricate and accurate surgeries, and viscoelastic devices might be utilized to operate a wider range of ocular ailments.

Key Players Landscape and Outlook

The global ophthalmic viscoelastic devices market consists of market players like Bausch & Lomb Incorporated, Alcon Laboratories, Inc., Johnson & Johnson Surgical Vision Inc., and others, who are expanding their product offerings and giving their customers access to a wide range of cutting-edge and novel products.

For instance, In January 2022, Glaukos Corporation announced that it received 510(k) clearance from the United States Food and Drug Administration (FDA) for its viscoelastic device named 'iPRIME Viscodelivery System'. Glaukos is an ophthalmic medtech and pharmaceutical company dedicated to developing novel therapies for managing glaucoma, retinal diseases, and corneal disorders. iPRIME Viscodelivery System is a single-use, sterile, minimally-invasive device for delivering viscoelastic fluid during ophthalmic surgeries.

Table of Contents

1. Research Methodology

2. Project Scope & Definitions

3. Executive Summary

4. Global Ophthalmic Viscoelastic Devices Market Outlook, 2017-2031F

  • 4.1. Market Size & Forecast
    • 4.1.1. By Value
    • 4.1.2. By Volume
  • 4.2. By Product Type
    • 4.2.1. Cohesive Ophthalmic Viscoelastic Devices
    • 4.2.2. Dispersive Ophthalmic Viscoelastic Devices
    • 4.2.3. Viscoadaptive Ophthalmic Viscoelastic Devices
    • 4.2.4. Higher Viscosity Dispersive Ophthalmic Viscoelastic Devices
  • 4.3. By Composition
    • 4.3.1. Sodium Hyaluronate
    • 4.3.2. Chondroitin Sulfate
    • 4.3.3. Hydroxypropyl Methylcellulose
  • 4.4. By Application
    • 4.4.1. Cataract Surgery
    • 4.4.2. Glaucoma Surgery
    • 4.4.3. Vitreoretinal Surgery
    • 4.4.4. Corneal Transplantation Surgery
    • 4.4.5. Other Applications
  • 4.5. By End-user
    • 4.5.1. Hospitals
    • 4.5.2. Eye Clinics
    • 4.5.3. Ambulatory Surgical Centers
    • 4.5.4. Academic and Research Institutes
    • 4.5.5. Others
  • 4.6. By Region
    • 4.6.1. North America
    • 4.6.2. Europe
    • 4.6.3. Asia Pacific
    • 4.6.4. South America
    • 4.6.5. Middle East & Africa
  • 4.7. By Company Market Share (%), 2023

5. Global Ophthalmic Viscoelastic Devices Market, By Region, 2017-2031F

  • 5.1. North America*
    • 5.1.1. Market Size & Forecast
      • 5.1.1.1. By Value
      • 5.1.1.2. By Volume
    • 5.1.2. By Product Type
      • 5.1.2.1. Cohesive Ophthalmic Viscoelastic Devices
      • 5.1.2.2. Dispersive Ophthalmic Viscoelastic Devices
      • 5.1.2.3. Viscoadaptive Ophthalmic Viscoelastic Devices
      • 5.1.2.4. Higher Viscosity Dispersive Ophthalmic Viscoelastic Devices
    • 5.1.3. By Composition
      • 5.1.3.1. Sodium Hyaluronate
      • 5.1.3.2. Chondroitin Sulfate
      • 5.1.3.3. Hydroxypropyl Methylcellulose
    • 5.1.4. By Application
      • 5.1.4.1. Cataract Surgery
      • 5.1.4.2. Glaucoma Surgery
      • 5.1.4.3. Vitreoretinal Surgery
      • 5.1.4.4. Corneal Transplantation Surgery
      • 5.1.4.5. Other Applications
    • 5.1.5. By End-user
      • 5.1.5.1. Hospitals
      • 5.1.5.2. Eye Clinics
      • 5.1.5.3. Ambulatory Surgical Centers
      • 5.1.5.4. Academic and Research Institutes
      • 5.1.5.5. Others
    • 5.1.6. United States*
      • 5.1.6.1. Market Size & Forecast
      • 5.1.6.1.1. By Value
      • 5.1.6.1.2. By Volume
      • 5.1.6.2. By Product Type
      • 5.1.6.2.1. Cohesive Ophthalmic Viscoelastic Devices
      • 5.1.6.2.2. Dispersive Ophthalmic Viscoelastic Devices
      • 5.1.6.2.3. Viscoadaptive Ophthalmic Viscoelastic Devices
      • 5.1.6.2.4. Higher Viscosity Dispersive Ophthalmic Viscoelastic Devices
      • 5.1.6.3. By Composition
      • 5.1.6.3.1. Sodium Hyaluronate
      • 5.1.6.3.2. Chondroitin Sulfate
      • 5.1.6.3.3. Hydroxypropyl Methylcellulose
      • 5.1.6.4. By Application
      • 5.1.6.4.1. Cataract Surgery
      • 5.1.6.4.2. Glaucoma Surgery
      • 5.1.6.4.3. Vitreoretinal Surgery
      • 5.1.6.4.4. Corneal Transplantation Surgery
      • 5.1.6.4.5. Other Applications
      • 5.1.6.5. By End-user
      • 5.1.6.5.1. Hospitals
      • 5.1.6.5.2. Eye Clinics
      • 5.1.6.5.3. Ambulatory Surgical Centers
      • 5.1.6.5.4. Academic and Research Institutes
      • 5.1.6.5.5. Others
    • 5.1.7. Canada
    • 5.1.8. Mexico

All segments will be provided for all regions and countries covered:

  • 5.2. Europe
    • 5.2.1. Germany
    • 5.2.2. France
    • 5.2.3. Italy
    • 5.2.4. United Kingdom
    • 5.2.5. Russia
    • 5.2.6. Netherlands
    • 5.2.7. Spain
    • 5.2.8. Turkey
    • 5.2.9. Poland
  • 5.3. South America
    • 5.3.1. Brazil
    • 5.3.2. Argentina
  • 5.4. Asia-Pacific
    • 5.4.1. India
    • 5.4.2. China
    • 5.4.3. Japan
    • 5.4.4. Australia
    • 5.4.5. Vietnam
    • 5.4.6. South Korea
    • 5.4.7. Indonesia
    • 5.4.8. Philippines
  • 5.5. Middle East & Africa
    • 5.5.1. Saudi Arabia
    • 5.5.2. UAE
    • 5.5.3. Israel
    • 5.5.4. South Africa

6. Market Mapping, 2023

  • 6.1. By Product Type
  • 6.2. By Composition
  • 6.3. By Application
  • 6.4. By End-user
  • 6.5. By Region

7. Macro Environment and Industry Structure

  • 7.1. Supply Demand Analysis
  • 7.2. Import Export Analysis - Volume and Value
  • 7.3. Supply/Value Chain Analysis
  • 7.4. PESTEL Analysis
    • 7.4.1. Political Factors
    • 7.4.2. Economic System
    • 7.4.3. Social Implications
    • 7.4.4. Technological Advancements
    • 7.4.5. Environmental Impacts
    • 7.4.6. Legal Compliances and Regulatory Policies (Statutory Bodies Included)
  • 7.5. Porter's Five Forces Analysis
    • 7.5.1. Supplier Power
    • 7.5.2. Buyer Power
    • 7.5.3. Substitution Threat
    • 7.5.4. Threat from New Entrant
    • 7.5.5. Competitive Rivalry

8. Market Dynamics

  • 8.1. Growth Drivers
  • 8.2. Growth Inhibitors (Challenges, Restraints)

9. Regulatory Framework and Innovation

  • 9.1. Clinical Trials
  • 9.2. Patent Landscape
  • 9.3. Regulatory Approvals
  • 9.4. Innovations/Emerging Technologies

10. Key Players Landscape

  • 10.1. Competition Matrix of Top Five Market Leaders
  • 10.2. Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
  • 10.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
  • 10.4. SWOT Analysis (For Five Market Players)
  • 10.5. Patent Analysis (If Applicable)

11. Pricing Analysis

12. Case Studies

13. Key Players Outlook

  • 13.1. Johnson & Johnson Surgical Vision Inc.
    • 13.1.1. Company Details
    • 13.1.2. Key Management Personnel
    • 13.1.3. Products & Services
    • 13.1.4. Financials (As reported)
    • 13.1.5. Key Market Focus & Geographical Presence
    • 13.1.6. Recent Developments
  • 13.2. Alcon Laboratories, Inc.
  • 13.3. Carl Zeiss Meditec AG
  • 13.4. Rumex International Corporation
  • 13.5. Altacor Limited
  • 13.6. Bausch & Lomb Incorporated
  • 13.7. Novartis International AG
  • 13.8. CVC Capital Partners SICAV- FIS SA
  • 13.9. Eyekon Medical Inc.
  • 13.10. Bohus BioTech AB
  • 13.11. Beaver Visitec Limited
  • 13.12. Neu Micromed International Pvt. Ltd.
  • 13.13. Rayner Intraocular Lenses Limited

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

14. Strategic Recommendations

15. About Us & Disclaimer

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1. Global Ophthalmic Viscoelastic Devices Market, By Value, In USD Billion, 2017-2031F
  • Figure 2. Global Ophthalmic Viscoelastic Devices Market, By Volume, In Million Units, 2017-2031F
  • Figure 3. Global Ophthalmic Viscoelastic Devices Market Share (%), By Product Type, 2017-2031F
  • Figure 4. Global Ophthalmic Viscoelastic Devices Market Share (%), By Composition, 2017-2031F
  • Figure 5. Global Ophthalmic Viscoelastic Devices Market Share (%), By Application, 2017-2031F
  • Figure 6. Global Ophthalmic Viscoelastic Devices Market Share (%), By End-user, 2017-2031F
  • Figure 7. Global Ophthalmic Viscoelastic Devices Market Share (%), By Region, 2017-2031F
  • Figure 8. North America Ophthalmic Viscoelastic Devices Market, By Value, In USD Billion, 2017-2031F
  • Figure 9. North America Ophthalmic Viscoelastic Devices Market, By Volume, In Million Units, 2017-2031F
  • Figure 10. North America Ophthalmic Viscoelastic Devices Market Share (%), By Product Type, 2017-2031F
  • Figure 11. North America Ophthalmic Viscoelastic Devices Market Share (%), By Composition, 2017-2031F
  • Figure 12. North America Ophthalmic Viscoelastic Devices Market Share (%), By Application, 2017-2031F
  • Figure 13. North America Ophthalmic Viscoelastic Devices Market Share (%), By End-user, 2017-2031F
  • Figure 14. North America Ophthalmic Viscoelastic Devices Market Share (%), By Country, 2017-2031F
  • Figure 15. United States Ophthalmic Viscoelastic Devices Market, By Value, In USD Billion, 2017-2031F
  • Figure 16. United States Ophthalmic Viscoelastic Devices Market, By Volume, In Million Units, 2017-2031F
  • Figure 17. United States Ophthalmic Viscoelastic Devices Market Share (%), By Product Type, 2017-2031F
  • Figure 18. United States Ophthalmic Viscoelastic Devices Market Share (%), By Composition, 2017-2031F
  • Figure 19. United States Ophthalmic Viscoelastic Devices Market Share (%), By Application, 2017-2031F
  • Figure 20. United States Ophthalmic Viscoelastic Devices Market Share (%), By End-user, 2017-2031F
  • Figure 21. Canada Ophthalmic Viscoelastic Devices Market, By Value, In USD Billion, 2017-2031F
  • Figure 22. Canada Ophthalmic Viscoelastic Devices Market, By Volume, In Million Units, 2017-2031F
  • Figure 23. Canada Ophthalmic Viscoelastic Devices Market Share (%), By Product Type, 2017-2031F
  • Figure 24. Canada Ophthalmic Viscoelastic Devices Market Share (%), By Composition, 2017-2031F
  • Figure 25. Canada Ophthalmic Viscoelastic Devices Market Share (%), By Application, 2017-2031F
  • Figure 26. Canada Ophthalmic Viscoelastic Devices Market Share (%), By End-user, 2017-2031F
  • Figure 27. Mexico Ophthalmic Viscoelastic Devices Market, By Value, In USD Billion, 2017-2031F
  • Figure 28. Mexico Ophthalmic Viscoelastic Devices Market, By Volume, In Million Units, 2017-2031F
  • Figure 29. Mexico Ophthalmic Viscoelastic Devices Market Share (%), By Product Type, 2017-2031F
  • Figure 30. Mexico Ophthalmic Viscoelastic Devices Market Share (%), By Composition, 2017-2031F
  • Figure 31. Mexico Ophthalmic Viscoelastic Devices Market Share (%), By Application, 2017-2031F
  • Figure 32. Mexico Ophthalmic Viscoelastic Devices Market Share (%), By End-user, 2017-2031F
  • Figure 33. Europe Ophthalmic Viscoelastic Devices Market, By Value, In USD Billion, 2017-2031F
  • Figure 34. Europe Ophthalmic Viscoelastic Devices Market, By Volume, In Million Units, 2017-2031F
  • Figure 35. Europe Ophthalmic Viscoelastic Devices Market Share (%), By Product Type, 2017-2031F
  • Figure 36. Europe Ophthalmic Viscoelastic Devices Market Share (%), By Composition, 2017-2031F
  • Figure 37. Europe Ophthalmic Viscoelastic Devices Market Share (%), By Application, 2017-2031F
  • Figure 38. Europe Ophthalmic Viscoelastic Devices Market Share (%), By End-user, 2017-2031F
  • Figure 39. Europe Ophthalmic Viscoelastic Devices Market Share (%), By Country, 2017-2031F
  • Figure 40. Germany Ophthalmic Viscoelastic Devices Market, By Value, In USD Billion, 2017-2031F
  • Figure 41. Germany Ophthalmic Viscoelastic Devices Market, By Volume, In Million Units, 2017-2031F
  • Figure 42. Germany Ophthalmic Viscoelastic Devices Market Share (%), By Product Type, 2017-2031F
  • Figure 43. Germany Ophthalmic Viscoelastic Devices Market Share (%), By Composition, 2017-2031F
  • Figure 44. Germany Ophthalmic Viscoelastic Devices Market Share (%), By Application, 2017-2031F
  • Figure 45. Germany Ophthalmic Viscoelastic Devices Market Share (%), By End-user, 2017-2031F
  • Figure 46. France Ophthalmic Viscoelastic Devices Market, By Value, In USD Billion, 2017-2031F
  • Figure 47. France Ophthalmic Viscoelastic Devices Market, By Volume, In Million Units, 2017-2031F
  • Figure 48. France Ophthalmic Viscoelastic Devices Market Share (%), By Product Type, 2017-2031F
  • Figure 49. France Ophthalmic Viscoelastic Devices Market Share (%), By Composition, 2017-2031F
  • Figure 50. France Ophthalmic Viscoelastic Devices Market Share (%), By Application, 2017-2031F
  • Figure 51. France Ophthalmic Viscoelastic Devices Market Share (%), By End-user, 2017-2031F
  • Figure 52. Italy Ophthalmic Viscoelastic Devices Market, By Value, In USD Billion, 2017-2031F
  • Figure 53. Italy Ophthalmic Viscoelastic Devices Market, By Volume, In Million Units, 2017-2031F
  • Figure 54. Italy Ophthalmic Viscoelastic Devices Market Share (%), By Product Type, 2017-2031F
  • Figure 55. Italy Ophthalmic Viscoelastic Devices Market Share (%), By Composition, 2017-2031F
  • Figure 56. Italy Ophthalmic Viscoelastic Devices Market Share (%), By Application, 2017-2031F
  • Figure 57. Italy Ophthalmic Viscoelastic Devices Market Share (%), By End-user, 2017-2031F
  • Figure 58. United Kingdom Ophthalmic Viscoelastic Devices Market, By Value, In USD Billion, 2017-2031F
  • Figure 59. United Kingdom Ophthalmic Viscoelastic Devices Market, By Volume, In Million Units, 2017-2031F
  • Figure 60. United Kingdom Ophthalmic Viscoelastic Devices Market Share (%), By Product Type, 2017-2031F
  • Figure 61. United Kingdom Ophthalmic Viscoelastic Devices Market Share (%), By Composition, 2017-2031F
  • Figure 62. United Kingdom Ophthalmic Viscoelastic Devices Market Share (%), By Application, 2017-2031F
  • Figure 63. United Kingdom Ophthalmic Viscoelastic Devices Market Share (%), By End-user, 2017-2031F
  • Figure 64. Russia Ophthalmic Viscoelastic Devices Market, By Value, In USD Billion, 2017-2031F
  • Figure 65. Russia Ophthalmic Viscoelastic Devices Market, By Volume, In Million Units, 2017-2031F
  • Figure 66. Russia Ophthalmic Viscoelastic Devices Market Share (%), By Product Type, 2017-2031F
  • Figure 67. Russia Ophthalmic Viscoelastic Devices Market Share (%), By Composition, 2017-2031F
  • Figure 68. Russia Ophthalmic Viscoelastic Devices Market Share (%), By Application, 2017-2031F
  • Figure 69. Russia Ophthalmic Viscoelastic Devices Market Share (%), By End-user, 2017-2031F
  • Figure 70. Netherlands Ophthalmic Viscoelastic Devices Market, By Value, In USD Billion, 2017-2031F
  • Figure 71. Netherlands Ophthalmic Viscoelastic Devices Market, By Volume, In Million Units, 2017-2031F
  • Figure 72. Netherlands Ophthalmic Viscoelastic Devices Market Share (%), By Product Type, 2017-2031F
  • Figure 73. Netherlands Ophthalmic Viscoelastic Devices Market Share (%), By Composition, 2017-2031F
  • Figure 74. Netherlands Ophthalmic Viscoelastic Devices Market Share (%), By Application, 2017-2031F
  • Figure 75. Netherlands Ophthalmic Viscoelastic Devices Market Share (%), By End-user, 2017-2031F
  • Figure 76. Spain Ophthalmic Viscoelastic Devices Market, By Value, In USD Billion, 2017-2031F
  • Figure 77. Spain Ophthalmic Viscoelastic Devices Market, By Volume, In Million Units, 2017-2031F
  • Figure 78. Spain Ophthalmic Viscoelastic Devices Market Share (%), By Product Type, 2017-2031F
  • Figure 79. Spain Ophthalmic Viscoelastic Devices Market Share (%), By Composition, 2017-2031F
  • Figure 80. Spain Ophthalmic Viscoelastic Devices Market Share (%), By Application, 2017-2031F
  • Figure 81. Spain Ophthalmic Viscoelastic Devices Market Share (%), By End-user, 2017-2031F
  • Figure 82. Turkey Ophthalmic Viscoelastic Devices Market, By Value, In USD Billion, 2017-2031F
  • Figure 83. Turkey Ophthalmic Viscoelastic Devices Market, By Volume, In Million Units, 2017-2031F
  • Figure 84. Turkey Ophthalmic Viscoelastic Devices Market Share (%), By Product Type, 2017-2031F
  • Figure 85. Turkey Ophthalmic Viscoelastic Devices Market Share (%), By Composition, 2017-2031F
  • Figure 86. Turkey Ophthalmic Viscoelastic Devices Market Share (%), By Application, 2017-2031F
  • Figure 87. Turkey Ophthalmic Viscoelastic Devices Market Share (%), By End-user, 2017-2031F
  • Figure 88. Poland Ophthalmic Viscoelastic Devices Market, By Value, In USD Billion, 2017-2031F
  • Figure 89. Poland Ophthalmic Viscoelastic Devices Market, By Volume, In Million Units, 2017-2031F
  • Figure 90. Poland Ophthalmic Viscoelastic Devices Market Share (%), By Product Type, 2017-2031F
  • Figure 91. Poland Ophthalmic Viscoelastic Devices Market Share (%), By Composition, 2017-2031F
  • Figure 92. Poland Ophthalmic Viscoelastic Devices Market Share (%), By Application, 2017-2031F
  • Figure 93. Poland Ophthalmic Viscoelastic Devices Market Share (%), By End-user, 2017-2031F
  • Figure 94. South America Ophthalmic Viscoelastic Devices Market, By Value, In USD Billion, 2017-2031F
  • Figure 95. South America Ophthalmic Viscoelastic Devices Market, By Volume, In Million Units, 2017-2031F
  • Figure 96. South America Ophthalmic Viscoelastic Devices Market Share (%), By Product Type, 2017-2031F
  • Figure 97. South America Ophthalmic Viscoelastic Devices Market Share (%), By Composition, 2017-2031F
  • Figure 98. South America Ophthalmic Viscoelastic Devices Market Share (%), By Application, 2017-2031F
  • Figure 99. South America Ophthalmic Viscoelastic Devices Market Share (%), By End-user, 2017-2031F
  • Figure 100. South America Ophthalmic Viscoelastic Devices Market Share (%), By Country, 2017-2031F
  • Figure 101. Brazil Ophthalmic Viscoelastic Devices Market, By Value, In USD Billion, 2017-2031F
  • Figure 102. Brazil Ophthalmic Viscoelastic Devices Market, By Volume, In Million Units, 2017-2031F
  • Figure 103. Brazil Ophthalmic Viscoelastic Devices Market Share (%), By Product Type, 2017-2031F
  • Figure 104. Brazil Ophthalmic Viscoelastic Devices Market Share (%), By Composition, 2017-2031F
  • Figure 105. Brazil Ophthalmic Viscoelastic Devices Market Share (%), By Application, 2017-2031F
  • Figure 106. Brazil Ophthalmic Viscoelastic Devices Market Share (%), By End-user, 2017-2031F
  • Figure 107. Argentina Ophthalmic Viscoelastic Devices Market, By Value, In USD Billion, 2017-2031F
  • Figure 108. Argentina Ophthalmic Viscoelastic Devices Market, By Volume, In Million Units, 2017-2031F
  • Figure 109. Argentina Ophthalmic Viscoelastic Devices Market Share (%), By Product Type, 2017-2031F
  • Figure 110. Argentina Ophthalmic Viscoelastic Devices Market Share (%), By Composition, 2017-2031F
  • Figure 111. Argentina Ophthalmic Viscoelastic Devices Market Share (%), By Application, 2017-2031F
  • Figure 112. Argentina Ophthalmic Viscoelastic Devices Market Share (%), By End-user, 2017-2031F
  • Figure 113. Asia-Pacific Ophthalmic Viscoelastic Devices Market, By Value, In USD Billion, 2017-2031F
  • Figure 114. Asia-Pacific Ophthalmic Viscoelastic Devices Market, By Volume, In Million Units, 2017-2031F
  • Figure 115. Asia-Pacific Ophthalmic Viscoelastic Devices Market Share (%), By Product Type, 2017-2031F
  • Figure 116. Asia-Pacific Ophthalmic Viscoelastic Devices Market Share (%), By Composition, 2017-2031F
  • Figure 117. Asia-Pacific Ophthalmic Viscoelastic Devices Market Share (%), By Application, 2017-2031F
  • Figure 118. Asia-Pacific Ophthalmic Viscoelastic Devices Market Share (%), By End-user, 2017-2031F
  • Figure 119. Asia-Pacific Ophthalmic Viscoelastic Devices Market Share (%), By Country, 2017-2031F
  • Figure 120. India Ophthalmic Viscoelastic Devices Market, By Value, In USD Billion, 2017-2031F
  • Figure 121. India Ophthalmic Viscoelastic Devices Market, By Volume, In Million Units, 2017-2031F
  • Figure 122. India Ophthalmic Viscoelastic Devices Market Share (%), By Product Type, 2017-2031F
  • Figure 123. India Ophthalmic Viscoelastic Devices Market Share (%), By Composition, 2017-2031F
  • Figure 124. India Ophthalmic Viscoelastic Devices Market Share (%), By Application, 2017-2031F
  • Figure 125. India Ophthalmic Viscoelastic Devices Market Share (%), By End-user, 2017-2031F
  • Figure 126. China Ophthalmic Viscoelastic Devices Market, By Value, In USD Billion, 2017-2031F
  • Figure 127. China Ophthalmic Viscoelastic Devices Market, By Volume, In Million Units, 2017-2031F
  • Figure 128. China Ophthalmic Viscoelastic Devices Market Share (%), By Product Type, 2017-2031F
  • Figure 129. China Ophthalmic Viscoelastic Devices Market Share (%), By Composition, 2017-2031F
  • Figure 130. China Ophthalmic Viscoelastic Devices Market Share (%), By Application, 2017-2031F
  • Figure 131. China Ophthalmic Viscoelastic Devices Market Share (%), By End-user, 2017-2031F
  • Figure 132. Japan Ophthalmic Viscoelastic Devices Market, By Value, In USD Billion, 2017-2031F
  • Figure 133. Japan Ophthalmic Viscoelastic Devices Market, By Volume, In Million Units, 2017-2031F
  • Figure 134. Japan Ophthalmic Viscoelastic Devices Market Share (%), By Product Type, 2017-2031F
  • Figure 135. Japan Ophthalmic Viscoelastic Devices Market Share (%), By Composition, 2017-2031F
  • Figure 136. Japan Ophthalmic Viscoelastic Devices Market Share (%), By Application, 2017-2031F
  • Figure 137. Japan Ophthalmic Viscoelastic Devices Market Share (%), By End-user, 2017-2031F
  • Figure 138. Australia Ophthalmic Viscoelastic Devices Market, By Value, In USD Billion, 2017-2031F
  • Figure 139. Australia Ophthalmic Viscoelastic Devices Market, By Volume, In Million Units, 2017-2031F
  • Figure 140. Australia Ophthalmic Viscoelastic Devices Market Share (%), By Product Type, 2017-2031F
  • Figure 141. Australia Ophthalmic Viscoelastic Devices Market Share (%), By Composition, 2017-2031F
  • Figure 142. Australia Ophthalmic Viscoelastic Devices Market Share (%), By Application, 2017-2031F
  • Figure 143. Australia Ophthalmic Viscoelastic Devices Market Share (%), By End-user, 2017-2031F
  • Figure 144. Vietnam Ophthalmic Viscoelastic Devices Market, By Value, In USD Billion, 2017-2031F
  • Figure 145. Vietnam Ophthalmic Viscoelastic Devices Market, By Volume, In Million Units, 2017-2031F
  • Figure 146. Vietnam Ophthalmic Viscoelastic Devices Market Share (%), By Product Type, 2017-2031F
  • Figure 147. Vietnam Ophthalmic Viscoelastic Devices Market Share (%), By Composition, 2017-2031F
  • Figure 148. Vietnam Ophthalmic Viscoelastic Devices Market Share (%), By Application, 2017-2031F
  • Figure 149. Vietnam Ophthalmic Viscoelastic Devices Market Share (%), By End-user, 2017-2031F
  • Figure 150. South Korea Ophthalmic Viscoelastic Devices Market, By Value, In USD Billion, 2017-2031F
  • Figure 151. South Korea Ophthalmic Viscoelastic Devices Market, By Volume, In Million Units, 2017-2031F
  • Figure 152. South Korea Ophthalmic Viscoelastic Devices Market Share (%), By Product Type, 2017-2031F
  • Figure 153. South Korea Ophthalmic Viscoelastic Devices Market Share (%), By Composition, 2017-2031F
  • Figure 154. South Korea Ophthalmic Viscoelastic Devices Market Share (%), By Application, 2017-2031F
  • Figure 155. South Korea Ophthalmic Viscoelastic Devices Market Share (%), By End-user, 2017-2031F
  • Figure 156. Indonesia Ophthalmic Viscoelastic Devices Market, By Value, In USD Billion, 2017-2031F
  • Figure 157. Indonesia Ophthalmic Viscoelastic Devices Market, By Volume, In Million Units, 2017-2031F
  • Figure 158. Indonesia Ophthalmic Viscoelastic Devices Market Share (%), By Product Type, 2017-2031F
  • Figure 159. Indonesia Ophthalmic Viscoelastic Devices Market Share (%), By Composition, 2017-2031F
  • Figure 160. Indonesia Ophthalmic Viscoelastic Devices Market Share (%), By Application, 2017-2031F
  • Figure 161. Indonesia Ophthalmic Viscoelastic Devices Market Share (%), By End-user, 2017-2031F
  • Figure 162. Philippines Ophthalmic Viscoelastic Devices Market, By Value, In USD Billion, 2017-2031F
  • Figure 163. Philippines Ophthalmic Viscoelastic Devices Market, By Volume, In Million Units, 2017-2031F
  • Figure 164. Philippines Ophthalmic Viscoelastic Devices Market Share (%), By Product Type, 2017-2031F
  • Figure 165. Philippines Ophthalmic Viscoelastic Devices Market Share (%), By Composition, 2017-2031F
  • Figure 166. Philippines Ophthalmic Viscoelastic Devices Market Share (%), By Application, 2017-2031F
  • Figure 167. Philippines Ophthalmic Viscoelastic Devices Market Share (%), By End-user, 2017-2031F
  • Figure 168. Middle East & Africa Ophthalmic Viscoelastic Devices Market, By Value, In USD Billion, 2017-2031F
  • Figure 169. Middle East & Africa Ophthalmic Viscoelastic Devices Market, By Volume, In Million Units, 2017-2031F
  • Figure 170. Middle East & Africa Ophthalmic Viscoelastic Devices Market Share (%), By Product Type, 2017-2031F
  • Figure 171. Middle East & Africa Ophthalmic Viscoelastic Devices Market Share (%), By Composition, 2017-2031F
  • Figure 172. Middle East & Africa Ophthalmic Viscoelastic Devices Market Share (%), By Application, 2017-2031F
  • Figure 173. Middle East & Africa Ophthalmic Viscoelastic Devices Market Share (%), By End-user, 2017-2031F
  • Figure 174. Middle East & Africa Ophthalmic Viscoelastic Devices Market Share (%), By Country, 2017-2031F
  • Figure 175. Saudi Arabia Ophthalmic Viscoelastic Devices Market, By Value, In USD Billion, 2017-2031F
  • Figure 176. Saudi Arabia Ophthalmic Viscoelastic Devices Market, By Volume, In Million Units, 2017-2031F
  • Figure 177. Saudi Arabia Ophthalmic Viscoelastic Devices Market Share (%), By Product Type, 2017-2031F
  • Figure 178. Saudi Arabia Ophthalmic Viscoelastic Devices Market Share (%), By Composition, 2017-2031F
  • Figure 179. Saudi Arabia Ophthalmic Viscoelastic Devices Market Share (%), By Application, 2017-2031F
  • Figure 180. Saudi Arabia Ophthalmic Viscoelastic Devices Market Share (%), By End-user, 2017-2031F
  • Figure 181. UAE Ophthalmic Viscoelastic Devices Market, By Value, In USD Billion, 2017-2031F
  • Figure 182. UAE Ophthalmic Viscoelastic Devices Market, By Volume, In Million Units, 2017-2031F
  • Figure 183. UAE Ophthalmic Viscoelastic Devices Market Share (%), By Product Type, 2017-2031F
  • Figure 184. UAE Ophthalmic Viscoelastic Devices Market Share (%), By Composition, 2017-2031F
  • Figure 185. UAE Ophthalmic Viscoelastic Devices Market Share (%), By Application, 2017-2031F
  • Figure 186. UAE Ophthalmic Viscoelastic Devices Market Share (%), By End-user, 2017-2031F
  • Figure 187. South Africa Ophthalmic Viscoelastic Devices Market, By Value, In USD Billion, 2017-2031F
  • Figure 188. South Africa Ophthalmic Viscoelastic Devices Market, By Volume, In Million Units, 2017-2031F
  • Figure 189. South Africa Ophthalmic Viscoelastic Devices Market Share (%), By Product Type, 2017-2031F
  • Figure 190. South Africa Ophthalmic Viscoelastic Devices Market Share (%), By Composition, 2017-2031F
  • Figure 191. South Africa Ophthalmic Viscoelastic Devices Market Share (%), By Application, 2017-2031F
  • Figure 192. South Africa Ophthalmic Viscoelastic Devices Market Share (%), By End-user, 2017-2031F
  • Figure 193. By Product Type Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 194. By Composition Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 195. By Application Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 196. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 197. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023